PPD's Lee Babiss On Virtual R&D In China: An Interview With PharmAsia News (Part 2 Of 2)
This article was originally published in PharmAsia News
Lee Babiss left his position as president of pharmaceutical research at Roche to become the executive vice president of global laboratory services at the Wilmington, North Carolina-based contract research organization PPD. In part one of an interview with PharmAsia News, Babiss spoke about the evolving relationships between pharmaceutical firms and CROs, including end-to-end virtualization of R&D (PharmAsia News, April 6, 2010).
You may also be interested in...
Lee Babiss left Roche, one of the world's largest pharmaceutical companies, for a contract research organization position in part because his days as president of drug research were filled less with driving research projects forward and more with containing his group's costs, a reflection of the current state of R&D productivity at major pharmaceutical firms.
China To Implement New Regulations For Patent Law; Companies Should Set Up Inventor Reward Policy To Prepare For Changes
SHANGHAI - China's State Council recently approved new implementation regulations for the country's Patent law, which clarifies procedural issues in line with new changes to the patent law that took effect last year
Roche Hits A Wall With Its Tarceva Patent Claims In India; Novartis Moves Supreme Court For Glivec Rights
MUMBAI - For the two Swiss drug giants Novartis and Roche, there was much action at India's Supreme Court Aug. 28 as they separately continued the fight to safeguard patents on their life-saving oncology drugs steadfastly challenged by health activists and generic drug manufacturers alike in India